Motion correction has potential to affect diagnosis or patient care.
There was better quantification and detection of PET-avid lesions with the addition of a motion correction algorithm, according to a study published in the Journal of Nuclear Medicine.
Researchers from the United Kingdom sought to determine the ability of their joint PET/MRI-based predictive motion model to correct respiratory motion in PET, demonstrating that the algorithm could improve lesion detectability and quantitation and reduce image artifacts.
Forty-two clinical PET/MRI patient datasets containing 162 PET-avid lesions were included in the study. The researchers used multiple tracers and multiple organ locations to apply their motion correction method to the datasets. Quantitative changes were calculated using SUV changes in avid lesions. Lesion detectability changes were explored with a study; two radiologists identified lesions in uncorrected and motion-corrected images and provided confidence scores.
The results showed mean increases of 12.4% for SUVpeak and 17.6% for SUVmax after motion correction were found. In the detectability study, confidence scores for detecting avid lesions increased, with a rise in mean score from 2.67 to 3.01 (of 4) after motion correction and a rise in detection rate from 74% to 84%. Of 162 confirmed lesions, 49 showed an increase in all three metrics-SUVpeak, SUVmax, and combined reader confidence score-whereas only two lesions showed a decrease.
The researchers also presented clinical case studies that demonstrated the effect of respiratory motion correction of PET data on patient management, with increased numbers of detected lesions, improved lesion sharpness and localization, and reduced attenuation-based artifacts.
They concluded that there were significant improvements in quantification and detection of PET-avid lesions, with specific case study examples showing where motion correction has the potential to affect diagnosis or patient care.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.